PDS Biotechnology
PDSB
PDSB
54 hedge funds and large institutions have $156M invested in PDS Biotechnology in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.11% less ownership
Funds ownership: 2.58% → 2.47% (-0.11%)
Holders
54
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$22M | |
| 2 | +$1.61M | |
| 3 | +$1.57M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$400K |
| 5 |
Goldman Sachs
New York
|
+$374K |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$593K | |
| 3 | -$362K | |
| 4 |
Millennium Management
New York
|
-$359K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$194K |